A recombinant polynucleotide comprising a nucleic acid sequence selected from the group consisting of: a) a nucleic acid sequence being at least 80% identical to the nucleic acid sequence as shown in SEQ ID NO: 1; b) a nucleic acid sequence being at least 80% identical to the nucleic acid sequence as shown by the sequence of nucleotide 1001 to nucleotide 57525 of SEQ ID NO: 1; c) a nucleic acid sequence being at least 80% identical to a nucleic acid sequence as shown by the sequence of nucleotide 12423 to nucleotide 52300 of SEQ ID NO: 1; d) a nucleic acid sequence being at least 80% identical to a nucleic acid sequence as shown by the sequence of nucleotide 7505 to nucleotide 55295 of SEQ ID NO: 1; e) a nucleic acid sequence being at least 80% identical to a nucleic acid sequence as shown by the sequence of nucleotide 18123 to nucleotide 52300 of SEQ ID NO: 1; f) a nucleic acid sequence being at least 80% identical to a nucleic acid sequence as shown in SEQ ID NOs: 2, 4, 6, 8, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44 or 46; g) a nucleic acid sequence encoding a polypeptide having an amino acid sequence being at least 80% identical to an amino acid sequence as shown in SEQ ID NOs: 3, 5, 7, 9, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 89, 105, 121, 142, 158, 169, 180, or 196; h) a nucleic acid sequence comprising at least one expression cassette for at least one polypeptide having an amino acid sequence being at least 80% identical to an amino acid sequence as shown in SEQ ID NOs: 3, 5, 7, 9, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47 89, 105, 121, 142, 158, 169. 180, or 196. a) a nucleic acid sequence being at least 80% identical to the nucleic acid sequence as shown in SEQ ID NO: 1; b) a nucleic acid sequence being at least 80% identical to the nucleic acid sequence as shown by the sequence of nucleotide 1001 to nucleotide 57525 of SEQ ID NO: 1; c) a nucleic acid sequence being at least 80% identical to a nucleic acid sequence as shown by the sequence of nucleotide 12423 to nucleotide 52300 of SEQ ID NO: 1; d) a nucleic acid sequence being at least 80% identical to a nucleic acid sequence as shown by the sequence of nucleotide 7505 to nucleotide 55295 of SEQ ID NO: 1; e) a nucleic acid sequence being at least 80% identical to a nucleic acid sequence as shown by the sequence of nucleotide 18123 to nucleotide 52300 of SEQ ID NO: 1; f) a nucleic acid sequence being at least 80% identical to a nucleic acid sequence as shown in SEQ ID NOs: 2, 4, 6, 8, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44 or 46; g) a nucleic acid sequence encoding a polypeptide having an amino acid sequence being at least 80% identical to an amino acid sequence as shown in SEQ ID NOs: 3, 5, 7, 9, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 89, 105, 121, 142, 158, 169, 180, or 196; h) a nucleic acid sequence comprising at least one expression cassette for at least one polypeptide having an amino acid sequence being at least 80% identical to an amino acid sequence as shown in SEQ ID NOs: 3, 5, 7, 9, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47 89, 105, 121, 142, 158, 169. 180, or 196. <EOS>